Zurich Cantonal Bank
SNDX icon

Zurich Cantonal Bank’s Syndax Pharmaceuticals SNDX Stock Holding History

Zurich Cantonal Bank’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Buy
36,151
+11,412
+46% +$237K ﹤0.01% 1694
2026
Q1 		$578K Buy
24,739
+4,198
+20% +$91.2K ﹤0.01% 1765
2025
Q4 		$432K Hold
20,541
– – ﹤0.01% 1875
2025
Q3 		$316K Hold
20,541
– – ﹤0.01% 1968
2025
Q2 		$192K Buy
20,541
+7,281
+55% +$80.1K ﹤0.01% 2156
2025
Q1 		$163K Sell
13,260
-4,731
-26% -$66.7K ﹤0.01% 2197
2024
Q4 		$238K Buy
17,991
+5,771
+47% +$98.8K ﹤0.01% 2071
2024
Q3 		$235K Sell
12,220
-15
-0.1% -$310 ﹤0.01% 2024
2024
Q2 		$251K Sell
12,235
-6,057
-33% -$127K ﹤0.01% 1925
2024
Q1 		$435K Buy
18,292
+4,166
+29% +$92.9K ﹤0.01% 1560
2023
Q4 		$305K Buy
14,126
+1,162
+9% +$17.9K ﹤0.01% 1830
2023
Q3 		$188K Sell
12,964
-108
-0.8% -$2.04K ﹤0.01% 2005
2023
Q2 		$274K Buy
13,072
+3,439
+36% +$71.6K ﹤0.01% 1720
2023
Q1 		$203K Sell
9,633
-99
-1% -$2.46K ﹤0.01% 1851
2022
Q4 		$248K Buy
9,732
+1,272
+15% +$29.7K ﹤0.01% 1699
2022
Q3 		$203K Hold
8,460
– – ﹤0.01% 1747
2022
Q2 		$163K Buy
8,460
+3,187
+60% +$53.1K ﹤0.01% 1920
2022
Q1 		$92K Sell
5,273
-1,033
-16% -$17.4K ﹤0.01% 2322
2021
Q4 		$138K Sell
6,306
-176
-3% -$3.25K ﹤0.01% 2328
2021
Q3 		$124K Buy
6,482
+9
+0.1% +$150 ﹤0.01% 2209
2021
Q2 		$111K Buy
6,473
+1,729
+36% +$31.7K ﹤0.01% 2168
2021
Q1 		$106K Buy
+4,744
New +$107K ﹤0.01% 2131

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Zurich Cantonal Bank's SNDX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Syndax Pharmaceuticals (SNDX) stake by 46% in Q2 2026, buying an estimated $237K and bringing the position to 36,151 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Zurich Cantonal Bank first reported a position in SNDX in Q1 2021 and has held it in 22 quarters since. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Zurich Cantonal Bank held 36,151 shares of Syndax Pharmaceuticals worth $790K as of Q2 2026.
  • Zurich Cantonal Bank bought 11,412 Syndax Pharmaceuticals shares in Q2 2026, an estimated $237K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1694 holding.
  • Zurich Cantonal Bank first reported a position in Syndax Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.